IADR Abstract Archives

Effects of Hydrogen Peroxide on Enamel During Chronic Exposure

Hydrogen peroxide bleaching strips provide unit dose applications of peroxide for safe and effective tooth bleaching.  Objectives:  This study examined the effects of hydrogen peroxide bleaching strips containing 6.0 % hydrogen peroxide on the surface integrity of human enamel.  Methods:  Human enamel blocks were sectioned and mounted in methacrylate.   Enamel was polished to a mirror finish with gamma alumina.  Color determinations (CIELAB) of standardized areas on surfaces were taken by image analysis and surfaces were pre-measured for surface microhardness.  Teeth were bleached with hydrogen peroxide bleaching strips (HPS) in a cycling regimen including continuous pooled saliva immersion with 4x/day 5 minute treatments in peroxide gels.    An untreated control group included specimens which underwent no cycling (UCTR) while a second control group (CTR) was untreated and cycled through saliva soaks.  All specimens were treated bid with slurries of Crest® Regular Formula NaF dentifrice (including a pretreatment period before bleaching).  Following 120 treatments bleaching color values and surface microhardness were re-determined.  Surface profilometry, SEM and air objective CLSM were used to confirm surface effects.   Results:   Colorimetric evaluations confirmed significant tooth bleaching for peroxide exposures.  VHN measurements for enamel following 120 treatments:  UTCL=366±24-nsd-CTR=366±23-nsd-  HPS=359±19.  Conclusions:  HPS treatments did not soften or etch surface enamel supporting the safety of this unit dose applied bleaching to oral hard tissue surfaces.   


Division: IADR/AADR/CADR General Session
Meeting: 2007 IADR/AADR/CADR General Session (New Orleans, Louisiana)
Location: New Orleans, Louisiana
Year: 2007
Final Presentation ID: 1762
Abstract Category|Abstract Category(s): Mineralized Tissue
Authors
  • St. John, Samuel  ( The Procter and Gamble Company, Mason, OH, USA )
  • Kozak, Km  ( The Procter and Gamble Company, Mason, OH, USA )
  • Zoladz, Jr  ( The Procter and Gamble Company, Mason, OH, USA )
  • White, Dj  ( The Procter and Gamble Company, Mason, OH, USA )
  • Duschner, Heinz  ( University of Mainz, Mainz, N/A, Germany )
  • Schwartz, Bo  ( University of Mainz, Mainz, N/A, Germany )
  • Goetz, H.  ( University of Mainz, Mainz, N/A, Germany )
  • Reinsch, G.  ( University of Mainz, Mainz, N/A, Germany )
  • SESSION INFORMATION
    Poster Session
    Therapeutics
    03/23/2007